Skip to main content
Equibles

FRANKLIN RESOURCES INC

Position in BBIO — BridgeBio Pharma, Inc.

CIK 38777 San Mateo, CA
Back to BBIO Full portfolio

Position in BBIO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$160,889,683
-$20,224,885 QoQ
Shares Held
2,160,173
-11.4% QoQ
Ownership
1.11%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#19
of 472 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FRANKLIN RESOURCES INC holds $9,184,405,765 across 177 Biotechnology names. BBIO ranks #10 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 2,771,839 $1,728,352,485
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,347,253 $1,662,680,977
3 ASND
Ascendis Pharma A/S
 1,862,503 $496,766,798
4 JAZZ
Jazz Pharmaceuticals plc
 2,040,250 $491,639,040
5 RVMD
Revolution Medicines, Inc.
 1,488,394 $278,746,426
6 INSM
INSMED Inc
 2,273,222 $242,370,927
7 LGND
Ligand Pharmaceuticals Inc
 752,044 $237,713,585
8 ARGX
Argenx SE
 224,930 $208,683,303

All Filings in BBIO

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $160,889,683 2,160,173
2026-03-31 $181,114,568 2,438,925
2025-12-31 $165,595,339 2,164,928
2025-09-30 $75,002,552 1,444,023
2025-06-30 $35,468,266 821,405
2025-03-31 $11,728,079 339,256
2024-12-31 $235,928 8,598
2024-09-30 $175,673 6,900
2024-06-30 $174,776 6,900
2024-03-31 $140,654 4,549
2021-12-31 $4,784,440 286,837
2021-09-30 $13,373,509 285,332
2021-06-30 $17,281,549 283,490
2021-03-31 $17,500,498 284,099
2020-12-31 $20,200,145 284,069
2020-09-30 $10,636,357 283,485
2020-06-30 $9,238,413 283,300
2020-03-31 $8,215,700 283,300